ConductScience.org, home

Paper41594677

Magnetic Nanocarriers with ICPTES- and GPTMS-Functionalized Quaternary Chitosan for pH-Responsive Doxorubicin Release.

Soares SF and 6 others. Biomolecules, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Magnetic Nanocarriers with ICPTES- and GPTMS-Functionalized Quaternary Chitosan for pH-Responsive Doxorubicin Release. Papers, record 41594677. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41594677

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Magnetic Nanocarriers with ICPTES- and GPTMS-Functionalized Quaternary Chitosan for pH-Responsive Doxorubicin Release.
PubMed
Journal
Biomolecules
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-07-01
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Soares SFSofia Fhttps://orcid.org/0000-0003-3172-5437
2Machado ALMAna L M
3Cardoso BSBeatriz S
4Marinheiro DDiogohttps://orcid.org/0000-0003-1265-5744
5Andrade NNelsonhttps://orcid.org/0000-0003-2600-8599
6Martel FFátimahttps://orcid.org/0000-0002-0525-3416
7Daniel-da-Silva ALAna Lhttps://orcid.org/0000-0001-6581-8880

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DoxorubicinMajor topic
ChitosanMajor topic
Drug CarriersMajor topic
Magnetite NanoparticlesMajor topic
Hydrogen-Ion Concentration
Humans
Drug Liberation
MCF-7 Cells
Silanes
Isocyanates
Antibiotics, Antineoplastic

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
UID/50011/2025 (DOI 10.54499/UID/50011/2025) & LA/P/0006/2020 (DOI 10.54499/LA/P/0006/2020)Fundação para a Ciência e TecnologiaPubMed
2023.06221.CEECIND/CP2840/CT0019Fundação para a Ciência e TecnologiaPubMed
10.54499/2021.05673.BDFundação para a Ciência e TecnologiaPubMed
CEECIND/03075/2018/CP1559/CT0020; DOI: 10.54499/CEECIND/03075/2018/CP1559/CT0020Fundação para a Ciência e TecnologiaPubMed

Source PubMed

Download CSV of grants

References41

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
139116977Recent advances in modified chitosan-based drug delivery systems for transmucosal applications: A comprehensive review.Int J Biol Macromol2024https://conductscience.org/library/papers/39116977PubMed
211297896Modeling and comparison of dissolution profiles.Eur J Pharm Sci2001https://conductscience.org/library/papers/11297896PubMed
336746307Recent advances in long-acting drug delivery systems for anticancer drug.Adv Drug Deliv Rev2023https://conductscience.org/library/papers/36746307PubMed
433202787Silane Coupling Agent Modifies the Mechanical Properties of a Chitosan Microfiber.Molecules2020https://conductscience.org/library/papers/33202787PubMed
535331246Nanocarrier cancer therapeutics with functional stimuli-responsive mechanisms.J Nanobiotechnology2022https://conductscience.org/library/papers/35331246PubMed
630472269Investigation of the properties of N-[(2-hydroxy-3-trimethylammonium) propyl] chloride chitosan derivatives.Int J Biol Macromol2019https://conductscience.org/library/papers/30472269PubMed
737478770Recent progress of targeted nanocarriers in diagnostic, therapeutic, and theranostic applications in colorectal cancer.Biomater Adv2023https://conductscience.org/library/papers/37478770PubMed
835213987Encapsulation, Release, and Cytotoxicity of Doxorubicin Loaded in Liposomes, Micelles, and Metal-Organic Frameworks: A Review.Pharmaceutics2022https://conductscience.org/library/papers/35213987PubMed
937149112Weibull β value for the discernment of drug release mechanism of PLGA particles.Int J Pharm2023https://conductscience.org/library/papers/37149112PubMed
1039518210Dual Antimicrobial Activity of HTCC and Its Nanoparticles: A Synergistic Approach for Antibacterial and Antiviral Applications Through Combined In Silico and In Vitro Studies.Polymers (Basel)2024https://conductscience.org/library/papers/39518210PubMed
1139458656Endosomal pH, Redox Dual-Sensitive Prodrug Micelles Based on Hyaluronic Acid for Intracellular Camptothecin Delivery and Active Tumor Targeting in Cancer Therapy.Pharmaceutics2024https://conductscience.org/library/papers/39458656PubMed
1233887349A comprehensive review on time-tested anticancer drug doxorubicin.Life Sci2021https://conductscience.org/library/papers/33887349PubMed
1339500815Chitosan-Based Nanoformulations: Preclinical Investigations, Theranostic Advancements, and Clinical Trial Prospects for Targeting Diverse Pathologies.AAPS PharmSciTech2024https://conductscience.org/library/papers/39500815PubMed
1440230636Iron oxide based magnetic nanoparticles for hyperthermia, MRI and drug delivery applications: a review.RSC Adv2025https://conductscience.org/library/papers/40230636PubMed
1526448863The endosomal-lysosomal system: from acidification and cargo sorting to neurodegeneration.Transl Neurodegener2015https://conductscience.org/library/papers/26448863PubMed
1637375753Recent Advances in Doxorubicin Formulation to Enhance Pharmacokinetics and Tumor Targeting.Pharmaceuticals (Basel)2023https://conductscience.org/library/papers/37375753PubMed
1740281790Advances in Targeted Delivery of Doxorubicin for Cancer Chemotherapy.Bioengineering (Basel)2025https://conductscience.org/library/papers/40281790PubMed
1830542607The effect of oxidative stress upon intestinal sugar transport: an in vitro study using human intestinal epithelial (Caco-2) cells.Toxicol Res (Camb)2018https://conductscience.org/library/papers/30542607PubMed
1936388459Precise delivery of doxorubicin and imiquimod through pH-responsive tumor microenvironment-active targeting micelles for chemo- and immunotherapy.Mater Today Bio2022https://conductscience.org/library/papers/36388459PubMed
2030318223Magnetic quaternary chitosan hybrid nanoparticles for the efficient uptake of diclofenac from water.Carbohydr Polym2019https://conductscience.org/library/papers/30318223PubMed

See all 41 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41594677

GET https://conductscience.org/api/papers/v1/41594677/references?page=2